Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non–small cell lung cancerCarolyn E. Reed, Valerie W. Rusch, Robert J. Downey et al.|Journal of Thoracic and Cardiovascular Surgery|2003Cited by 301
Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications.David J. Kwiatkowski, David J. Sugarbaker, David H. Harpole et al.|Journal of Clinical Oncology|1998Cited by 188